Kirchner, J., Kirchner, J., Plesca, I., Rothe, R., Rothe, R., Resag, A., . . . Schmitz, M. (2024, June). Type I conventional dendritic cells and CD8+ T cells predict favorable clinical outcome of head and neck squamous cell carcinoma patients. Frontiers in Immunology.
Chicago Style (17th ed.) CitationKirchner, Johanna, et al. "Type I Conventional Dendritic Cells and CD8+ T Cells Predict Favorable Clinical Outcome of Head and Neck Squamous Cell Carcinoma Patients." Frontiers in Immunology Jun. 2024.
MLA (9th ed.) CitationKirchner, Johanna, et al. "Type I Conventional Dendritic Cells and CD8+ T Cells Predict Favorable Clinical Outcome of Head and Neck Squamous Cell Carcinoma Patients." Frontiers in Immunology, Jun. 2024.
Warning: These citations may not always be 100% accurate.